Healthcare provider profile · identity verified

Fawad Khaliq

Internal Medicine · TOWSON, MD · NPI 1104289750

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	416	109
Amlodipine Besylate	Amlodipine Besylate	341	103
Rosuvastatin Calcium	Rosuvastatin Calcium	331	102
Gabapentin	Gabapentin	292	87
Levothyroxine Sodium	Levothyroxine Sodium	290	68
Pantoprazole Sodium	Pantoprazole Sodium	272	95
Losartan Potassium	Losartan Potassium	238	64
Potassium Chloride	Potassium Chloride	187	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	183	37
Metoprolol Succinate	Metoprolol Succinate	169	51
Tamsulosin Hcl	Tamsulosin Hcl	160	44
Furosemide	Furosemide	155	48
Metformin Hcl	Metformin Hcl	148	40
Omeprazole	Omeprazole	147	39
Jardiance	Empagliflozin	141	33
Lisinopril	Lisinopril	138	36
Methocarbamol	Methocarbamol	137	55
Zolpidem Tartrate	Zolpidem Tartrate	134	19
Albuterol Sulfate Hfa	Albuterol Sulfate	130	44
Carvedilol	Carvedilol	130	36
Duloxetine Hcl	Duloxetine Hcl	127	36
Mirtazapine	Mirtazapine	120	34
Olmesartan Medoxomil	Olmesartan Medoxomil	118	36
Mounjaro	Tirzepatide	112	19
Metformin Hcl Er	Metformin Hcl	111	35
Pravastatin Sodium	Pravastatin Sodium	106	22
Metoprolol Tartrate	Metoprolol Tartrate	103	28
Hydrochlorothiazide	Hydrochlorothiazide	97	31
Tizanidine Hcl	Tizanidine Hcl	92	21
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	85	23
Escitalopram Oxalate	Escitalopram Oxalate	83	19
Meloxicam	Meloxicam	82	23
Tramadol Hcl	Tramadol Hcl	80	18
Ozempic	Semaglutide	77	14
Hydroxyzine Hcl	Hydroxyzine Hcl	75	30
Alendronate Sodium	Alendronate Sodium	73	13
Methylprednisolone	Methylprednisolone	71	59
Simvastatin	Simvastatin	71	22
Doxycycline Hyclate	Doxycycline Hyclate	70	63
Fluticasone Propionate	Fluticasone Propionate	69	29
Allopurinol	Allopurinol	68	24
Glimepiride	Glimepiride	66	19
Trulicity	Dulaglutide	64	12
Acetaminophen-Codeine	Acetaminophen With Codeine	63	16
Azithromycin	Azithromycin	61	55
Buspirone Hcl	Buspirone Hcl	60	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	19
Fluoxetine Hcl	Fluoxetine Hcl	55	11
Bupropion Xl	Bupropion Hcl	54	14
Clopidogrel	Clopidogrel Bisulfate	52	18
Montelukast Sodium	Montelukast Sodium	52	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	50	20
Hydralazine Hcl	Hydralazine Hcl	50	11
Dicyclomine Hcl	Dicyclomine Hcl	47	13
Citalopram Hbr	Citalopram Hydrobromide	46	suppressed
Eliquis	Apixaban	46	13
Sertraline Hcl	Sertraline Hcl	46	16
Fluconazole	Fluconazole	44	26
Amitriptyline Hcl	Amitriptyline Hcl	43	11
Synthroid	Levothyroxine Sodium	43	13
Trazodone Hcl	Trazodone Hcl	41	15
Alprazolam	Alprazolam	40	suppressed
Famotidine	Famotidine	39	18
Januvia	Sitagliptin Phosphate	39	11
Hydroxyzine Pamoate	Hydroxyzine Pamoate	37	suppressed
Ropinirole Hcl	Ropinirole Hcl	37	suppressed
Atenolol	Atenolol	36	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	suppressed
Lorazepam	Lorazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	34	suppressed
Ondansetron Odt	Ondansetron	32	20
Clobetasol Propionate	Clobetasol Propionate	31	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	suppressed
Temazepam	Temazepam	30	suppressed
Bumetanide	Bumetanide	29	11
Celecoxib	Celecoxib	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	14
Donepezil Hcl	Donepezil Hcl	28	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	16
Pregabalin	Pregabalin	26	suppressed
Primidone	Primidone	26	suppressed
Doxepin Hcl	Doxepin Hcl	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Nifedipine Er	Nifedipine	24	suppressed
Symbicort	Budesonide/Formoterol Fumarate	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide	Glipizide	22	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	22	suppressed
Valsartan	Valsartan	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	13
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Calcitriol	Calcitriol	20	suppressed
Neomycin-Polymyxin-Hydrocort	Neomycin/Polymyxin B/Hydrocort	20	20
Xarelto	Rivaroxaban	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	12
Propranolol Hcl Er	Propranolol Hcl	19	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Clotrimazole	Clotrimazole	17	15
Estradiol	Estradiol	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	16
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Finasteride	Finasteride	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Naproxen	Naproxen	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Lansoprazole	Lansoprazole	14	suppressed
Mupirocin	Mupirocin	14	11
Myrbetriq	Mirabegron	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Clonazepam	Clonazepam	13	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	13	suppressed
Linzess	Linaclotide	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Terbinafine Hcl	Terbinafine Hcl	13	12
Tradjenta	Linagliptin	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Cevimeline Hcl	Cevimeline Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Olanzapine	Olanzapine	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Telmisartan	Telmisartan	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Ramipril	Ramipril	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed
Verapamil Sr	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error